Mediators of racial and ethnic inequities in clinical trial participation among patients with cancer, 2011-2023
To improve racial and ethnic diversity in cancer trials, efforts to address barriers related to adverse neighborhood SDOH factors are necessary.
Authors
- Gregory S. Calip (ORCID: https://orcid.org/0000-0002-7744-3518)
- Somnath Sarkar (ORCID: https://orcid.org/0000-0002-8158-3847)
- Ivy Altomare (ORCID: https://orcid.org/0000-0002-1222-885X)
- Jenny S. Guadamuz (ORCID: https://orcid.org/0000-0002-2312-4140)
- Ronac Mamtani (ORCID: https://orcid.org/0000-0002-8267-5356)
- Xiaoliang Wang (ORCID: https://orcid.org/0000-0001-5184-2935)
- Wendy Castillo (ORCID: https://orcid.org/0000-0003-1336-8106)
Institutions
- University of Southern California (US)
- University of Maryland, Baltimore (US)
- AbbVie (United States) (US)
- Berkeley Public Health Division (US)
- Flatiron Health (United States) (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- JNCI Cancer Spectrum
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1093/jncics/pkae085
- Citations
- 6
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 3.26
Funders
- American Association for Cancer Research
- Flatiron Health
- National Institute on Minority Health and Health Disparities